The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.
about
The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@en
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@nl
type
label
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@en
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@nl
prefLabel
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@en
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@nl
P2093
P2860
P356
P1433
P1476
The pentapeptide Gly-Thr-Gly-L ...... ng the expression of cyclinD1.
@en
P2093
Deokbum Park
Dooil Jeoung
Doyong Jeon
Hansoo Lee
Jongseon Choe
Young Myeong Kim
Youngmi Kim
Yun Sil Lee
P2860
P304
13632-13651
P356
10.18632/ONCOTARGET.14621
P407
P577
2017-01-13T00:00:00Z